Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Japanese Red Cross Society (JRCS) is a major humanitarian organization and a central pillar of Japan's healthcare infrastructure, operating under the Japanese Red Cross Society Act. It holds a government-mandated monopoly on the collection, testing, and distribution of blood products for transfusion throughout Japan. Beyond blood services, the JRCS operates a massive network of over 90 hospitals that provide specialized medical care, emergency services, and disaster response. The organization is heavily involved in research and development related to transfusion safety, infectious disease screening, and the development of plasma-derived therapies. Through its partnership in the Japan Blood Products Organization, it contributes significantly to the domestic supply of essential plasma medicines like albumin and immunoglobulins. The JRCS also manages nursing colleges and social welfare facilities, making it one of the largest healthcare entities in the country.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Japanese Red Cross Society.